Serial evoked potential studies and MRI imaging in chronic progressive multiple sclerosis

Area of Science:

• Neuroscience
• Clinical Neurology
• Medical Imaging

Background:

• Multiple Sclerosis (MS) progression is often monitored using disability-based endpoints.
• Laboratory markers are sought to provide additional, objective measures of disease progression.
• Evoked potentials and MRI are frequently used in MS clinical studies.

Purpose of the Study:

• To evaluate the utility of serial evoked potentials and MRI in assessing disease progression in chronic progressive MS.
• To determine if laboratory markers change significantly over time in progressive MS.
• To compare changes in visual evoked potentials (VEP), brainstem auditory evoked potentials (BAEP), and MRI plaque burden with disability scores.

Main Methods:

• 11 patients with chronic progressive MS underwent serial VEP, BAEP, and MRI scans over 1.5 years.
• Disability was assessed using Kurtzke EDSS, Ambulation Index, and Neurological Rating Score.
• Changes in VEP P100 latency, BAEP I-V intrapeak latency, and MRI T(2) plaque burden were analyzed.

Main Results:

• No significant changes were observed in disability scores (EDSS, Ambulation Index, Neurological Rating Score) over the study period.
• Visual evoked potentials (VEP P100 latency) showed significant progression.
• Brainstem auditory evoked potentials (BAEP I-V intrapeak latency) and MRI T(2) plaque burden did not show significant progression.

Conclusions:

• Serial VEP testing can serve as a valuable complementary endpoint for assessing disease progression in chronic progressive MS.
• VEPs offer a sensitive laboratory marker that may detect changes not evident in standard disability measures or MRI over a 1.5-year period.
• Further research may explore the role of VEPs in long-term MS outcome prediction.